Eliana Clark - 01 Jul 2024 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Signature
/s/ James Basta, attorney-in-fact
Issuer symbol
NTLA
Transactions as of
01 Jul 2024
Net transactions value
-$9,287
Form type
4
Filing time
03 Jul 2024, 13:15:04 UTC
Previous filing
05 Mar 2024
Next filing
06 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTLA Common Stock Sale $9,287 -405 -0.56% $22.93 71,470 01 Jul 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of 405 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 28, 2024.